GSDME has demonstrated inhibitory effects on cell proliferation and tumor progression in gastric cancer (GC), melanoma, colorectal cancer (CRC), and breast cancer, where its expression is upregulated, indicating its potential role as a tumor-suppressing agent (25, 34, 92). The gene discussed is GSDME; the disease is gastric cancer.